Anti-fungal mechanisms of micafungin: Enzymological and morphological studies of micafungin action against Candida albicans and Aspergillus fumigatus

Japanese Journal of Chemotherapy

Volumn 50, Issue , 2002, Pages 20-29

  Yamaguchi, Hideyo ^a   Nishiyama, Yayoi ^a   Uchida, Katsuhisa ^a   Hatano, Kazuo ^b   Morishita, Yoshihiko ^b   author>, ToruNakai ^b   Ikeda, Fumiaki ^b   Mutoh, Seitaro ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; CHITIN; DNA; MANNAN; MICAFUNGIN; RNA;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CELL DIVISION; CELL STRUCTURE; CELL SWELLING; CELL WALL; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; DRUG ACTIVITY; DRUG MECHANISM; ENZYMOLOGY; FUNGAL CELL; FUNGAL MORPHOLOGY; FUNGAL SPORE GERMINATION; FUNGUS HYPHAE; INHIBITION KINETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0036924506     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: 10.11250/chemotherapy1995.50.Supplement1_20     Document Type: Article

References (52)

1. Ampel N M : Emerging disease issues and fungal pathogens associated with HIV infection. Emerg. Infect. Dis. 2 : 109~116, 1996
2. Andriole V T : Current and future antifungal therapy : new targets for antifungal agents. J. Antimicrob. Chemother. 44 : 151~162, 1999
3. Wade J C : Treatment of fungal and other opportunistic infections in immunocompromised patients. Leukemia. 11 Suppl 4 : S 38~39, 1997
4. Chimelli L, Mahler-Araújo M B : Fungal infections. Brain. Pathol. 7 : 613~627, 1997
5. Vermes A, Guchelaar HJ, Dankert J, Flucytosine : A review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J. Antimicrob. Chemother. 46 : 171~179, 2000
6. Robinson R F, Nahata M C : A comparative review of conventional and lipid formulations of amphotericin B. J. Clin. Pharm. Ther. 24 : 249~257, 1999
7. Gates C, Pinney R J : Amphotericin B and its delivery by liposomal and lipid formulations. J. Clin. Pharm. Ther. 18 : 147~153, 1993
8. Hofmann H : Fungal infections of the skin and mucous membranes : new therapies and the development of azole resistant yeasts. Curr. Opin. Infect. Dis. 10 : 96~100, 1997
9. Sangeorzan J A, Bradley S F, He X, et. al. : Epidemiology of oral candidiasis in HIV-infected patients : colonization, infection, treatment, and emergence of fluconazole resistance. Am. J. Med. 97 : 339~346, 1994
10. Redding S, Smith J, Farinacci G, et. al. : Resistnce of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS : documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18 : 240-242, 1994
11. Iwamoto T, Fujie A, Sakamoto K, et. al. : WF 11899 A, B and C, novel antifungal lipopeptides. I. Taxonomy, fermentation, isolation and physico-chemical properties. J. Antibiotics. 47 : 1084~1091, 1994
12. Iwamoto T, Fujie A, Nitta K, et. al. : WF 11899 A, B and C, novel antifungal lipopeptides. II. Biological properties. J. Antibiotics. 47 : 1092~1097, 1994
13. Tomishima M, Ohki H, Yamada A, et. al. : FK 463, a novel water-soluble echinocandin lipopeptide : synthesis and antifungal activity. J. Antibiotics. 52 : 674~676, 1999
14. Hatano K, Morishita Y, Nakai T, et. al. : Antifungal mechanism of FK 463 against Candida albicans and Aspergillus fumigatus. J. Antibiotics. 55 : 219~222, 2002
15. Nishiyama Y, Uchida K, Yamaguchi H : Morphological changes of Candida albicans induced by micafungin (FK 463), a water-soluble echinocandin -like lipopeptide. J. Electron Microsc. in press.
16. Dixon M : The determination of enzyme inhibitor constants. Biochem. J. 55 : 170~171, 1953
17. Sburlati A, Cabib E : Chitin synthetase 2, a presumptive participant in septum formation in Saccharomyces cerevisiae. J. Biol. Chem. 261 : 15147~15152, 1986
18. Behrens N H, Cabib E : The biosynthesis of mannan in Saccharomyces carlsbergensis. J. Biol. Chem. 243 : 502~509, 1968
19. Kossaczká Z, Drgoňová J, Podobová B, at al. : Accumulation of golgi-specific mannosyltrans-ferases in Candida albicans cells grown in the presence of brefeldin A. Can. J. Microbiol. 41 : 971~977, 1995
20. Yamaguchi H, Hiratani T, Iwata K, et. al. : Studies on the mechanism of antifungal action of aculeacin A. J. Antibiotics. 35 : 210~219, 1982
21. Lehrer R I, Cline M J : Interaction of Candida albicans with human leukocytes and serum. J. Bacteriol. 98 : 996~1004, 1969
22. Debono M, Gordee R S : Antibiotics that inhibit fungal cell wall development. Annu. Rev. Microbiol. 48 : 471~497, 1994
23. Chiou C C, Groll A H, Walsh T J : New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. Oncolog. 5 : 120~135, 2000
24. Beaulieu D, Tang J, Yan S B, et. al. : Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)-β-D-glucan synthase. Antimicrob. Agents. Chemother. 38 : 937~944, 1994
25. Sawistowska-Schroder E T, Kerridge D, Perry H : Echinocandin inhibition of 1, 3-β-D-glucan synthase from Candida albicans. FEBS Letters. 173 : 134~138, 1984
26. Taft C S, Stark T, Selitrennikoff C P : Cilofungin (LY 121019) inhibits Candida albicans (1, 3)-β-d -glucan synthase activity. Antimicrob. Agents. Chemother. 32 : 1901~1903, 1988
27. Taft C S, Selitrennikoff C P : LY 121019 inhibits Neurospora crassa growth and (1,3)-β-D-glucan synthase. J. Antibiotcs 41 : 697~701, 1988
28. Tang J, Parr Jr. T R : W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1, 3)-β-D-glucan synthase. Antimicrob. Agents. Chemother. 35 : 99~103, 1991
29. Douglas C M, Marrinan J A, Li W, et. al. : A Saccharomyces cerevisiae mutant with echinocandin -resistant 1,3-β-D-glucan synthase. J. Bacteriol. 176 : 5686~5696, 1994
30. Kurtz M B, Heath I B, Marrinan J, et. al. : Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrob. Agents. Chemother. 38 : 1480~1489, 1994
31. Shiota M, Nakajima T, Satoh A, et. al. : Comparison of β-glucan structures in a cell wall mutant of Saccharomyces cerevisiae and the wild type. J. Biochem. 98 : 1301~1307, 1985
32. Inouhe M, Sugo E, Tohoyama H, et. al. : Cell wall metabolism and autolytic activities of the yeast Saccharomyces exiguus. Int. J. Biol. Macromol. 21 : 11~14, 1997
33. Gorman J, Taruo P, LaBerge M, et. al. : Timing of enzyme synthesis during synchronous division in yeast. Biochem. Biophys. Res. Commun. 15 : 43~49, 1964
34. Varona R, Pé;rez P, Durán A : Effect of papulacandin B on β-glucan synthesis in Schizosaccharomyces pombe. FEMS. Microb. Lett. 20 : 243~247, 1983
35. Hiura N, Nakajima T, Matsuda K : Two cell wall β -D-glucans from Neurospora crassa. Agric. Biol. Chem. 47 : 1317~1322, 1983
36. Hiura N, Honjyo I, Nakajima T, et. al. : Change of the structure of cell wall β-l, 3-β-D-glucan with the growth of Neurospora crassa cells. Agric. Biol. Chem. 48 : 1041~1047, 1984
37. Inoue S B, Takewaki N, Takasuka T, et. al. : A Saccharomyces cerevisiae mutant with echinocandin -resistant 1,3-β-D-glucan synthase. Eur. J. Biochem. 231 : 845~854, 1995
38. Douglas C M, D'ippolito J A, Shei G J, et. al. : Identification of the FKS1 gene of Candida albicans as the essential target of 1, 3-β-D-glucan synthase inhibitors. Antimicrob. Agents. Chemother. 41 : 2471~2479, 1997
39. Mio T, Adachi-Shimizu M, Tachibana Y, et. al. : Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in β-l, 3-glucan synthesis. J. Bacteriol. 179 : 4096~4105, 1997
40. Douglas C M, Foor F, Marrinan J A, et. al. : The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1, 3-β-D-glucan synthase. Proc. Natl. Acad. Sci. USA. 91 : 12907~12911, 1994
41. Kondoh O, Tachibana Y, Ohya Y, et. al. : Cloning of the RHO1 gene from Candida albicans and its regulation of β-l, 3-glucan synthesis. J. Bacteriol. 179 : 7734~7741, 1997
42. Mazur P, Baginsky W : In vitro activity of 1,3-β-D -glucan synthase requires the GTP-binding protein Rho 1. J. Biol. Chem. 271 : 14604~14609, 1996
43. Arellano M, Durán A, Pé;rez P : Rho 1 GTPase activates the (l-3)-β-D-glucan synthase and is involved in Schizosaccharomyces pombe morphogenesis. EMBO. J. 15 : 4584~4591, 1996
44. Drgonová J, Drgon T, Tanaka K, et. al. : Rho 1 p, a yeast protein at the interface between cell polarization and morphogenesis. Science. 272 : 277~279, 1996
45. Qadota H, Python C P, Inoue S B, et. al. : Identification of yeast Rho 1 p GTPase as a regulatory subunit of 1,3-β-glucan synthase. Science. 272 : 279~281, 1996
46. Kelly R, Register E, Hsu M J, et. al. : Isolation of a gene involved in 1,3-β-glucan synthesis in Aspergillus nidulans and purification of the corresponding protein. J. Bacteriol. 178 : 4381~4391, 1996
47. Kurtz M B, Douglas C M : Lipopeptide inhibitors of fungal glucan synthase. J. Medic. Vet. Mycol. 35 : 79~86, 1997
48. El-Sherbeini M, Clemas J A : Cloning and characterization of GNS1 : a Saccharomyces cerevisiae gene involved in synthesis of 1,3-β-glucan in vitro. J. Bacteriol. 177 : 3227~3234, 1995
49. El-Sherbeini M, Clemas J A : Nikkomycin Z supersensitivity of an echinocandin-resistant mutant of Saccharomyces cerevisiae. Antimicro. Agents. Chemother. 39 : 200~207, 1995
50. Mazur P, Morin N, Baginsky W, et. al. : Differential expression and function of two homologous subunits of yeast 1,3-β-D-glucan synthase. Mol. Cell. Biol. 15 : 5671~5681, 1995
51. Radding J A, Heidler S A, Turner W W : Photoaffinity analog of the semisynthetic echinocan-din LY 303366 : identification of echinocandin targets in Candida albicans. Antimicrob. Agents. Chemother. 42 : 1187~1194, 1998
52. Cabib E, Drgonová J, Drgon T : Role of small G proteins in yeast cell polarization and wall biosynthesis. Annu. Rev. Biochem. 67 : 307~333, 1998